Novo Nordisk
NVO
#114
Rank
A$238.03 B
Marketcap
A$53.53
Share price
-1.20%
Change (1 day)
-61.94%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): A$31.74 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$47.70 Billion. , an increase over its 2024 earnings that were of A$26.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 A$28.99 B9.13%
2024 A$26.57 B22.84%
2023 A$21.63 B57.81%
2022 A$13.70 B5.24%
2021 A$13.02 B12.38%
2020 A$11.59 B13.11%
2019 A$10.24 B-3.45%
2018 A$10.61 B1.88%
2017 A$10.41 B4.3%
2016 A$9.98 B10.32%
2015 A$9.05 B7.47%
2014 A$8.42 B3.4%
2013 A$8.14 B19.09%
2012 A$6.84 B15.58%
2011 A$5.91 B16.58%
2010 A$5.07 B25.66%
2009 A$4.04 B10.68%
2008 A$3.65 B55.82%
2007 A$2.34 B7.02%
2006 A$2.18 B19.05%
2005 A$1.83 B10.55%
2004 A$1.66 B
2002 A$1.16 B-14.39%
2001 A$1.36 B-52.82%
2000 A$2.89 B250%
1999 A$0.82 B31.21%
1998 A$0.63 B34.31%
1997 A$0.46 B11.46%
1996 A$0.42 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.40 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.32 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.15 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.64 B-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.59 B 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.77 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$11.27 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA